Interpace Biosciences, Inc. (IDXG)
1.13
+0.08
(+7.62%)
USD |
OTCM |
Jan 09, 16:00
Interpace Biosciences EPS Diluted (Quarterly): 0.0329 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| FONAR Corp. | 0.3368 |
| XWELL, Inc. | -0.2557 |
| ProPhase Labs, Inc. | -1.646 |
| Veracyte, Inc. | 0.2401 |
| Insight Molecular Diagnostics, Inc. | -0.3388 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.011M |
| Revenue (Quarterly) | 8.756M |
| Total Expenses (Quarterly) | 7.745M |
| Enterprise Value | 5.841M |
| Gross Profit Margin (Quarterly) | 62.12% |
| Profit Margin (Quarterly) | 11.55% |
| Earnings Yield | 23.81% |
| Operating Earnings Yield | 25.17% |
| Normalized Earnings Yield | 24.90 |